Fellow Investor,
The FDA just granted a breakthrough cancer treatment an unusual legal ruling… one that’s moved it quickly through clinical trials.
Once they approve this new cutting-edge therapy – called “Alpha Cells” – shares of the tiny $5 stock behind the development cou...
Did the FDA just tip its hand?
No comments:
Post a Comment